Feb 10, 2015
Organised by the French Senate and the ESSEC business school since 1999, Tremplin Entreprises is the most prestigious business plan contest for innovative companies in France. This is the third national award received by Antabio in less than a year, after the Septuors...
Dec 2, 2014
Antabio announces that it will receive EUR 90,000 in funding from the Midi-Pyrénées Region to support the expansion of its R&D capabilities in Labège. This funding will be awarded to Antabio under the Innovative SMEs Support Contracts scheme (“Contrat d’Appui PME...
Jul 23, 2014
Antabio annonce que son projet de découverte de nouveaux traitements pour les patients atteints de mucoviscidose a été primé par le Concours Mondial de l’Innovation 2030.Labège, France, 23 juillet 2014. Antabio, société biopharmaceutique française spécialisée dans la...
Jun 2, 2014
Antabio’s profile is featured in a double-page article of the June 2014 special issue on infectious diseases of Nature Biopharma Dealmakers.The article describes the company’s history since its inception featuring some of its most innovative achievements, including...
Mar 10, 2014
Harlow, UK and Labège, France, 10th March 2014. Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration partner Antabio...
